Table 1.

Clinical and pathological characteristics

Variable	Median [IQR] or n (%)
Pre-operative PSA (ng/ml); median [IQR]	7.95 [5.45, 12.1]
Age (years); median [IQR]	63 [59, 68]
Non-white race	11/163 (6.75)
Grade group
2	29/163 (17.8)
3	42/163 (25.8)
4	45/163 (27.6)
5	47/163 (28.8)
Positive margins	50/163 (30.7)
Stage
2	70/163 (42.9)
3a	69/163 (42.3)
3b	24/163 (14.7)
Lymph node dissection	115/163 (70.6)
Positive lymph nodes	18/115 (15.7)
Biochemical recurrence	76 (47)
Overall death	7 (4)
Follow-up (months); median [IQR]	60 [29.5, 83.5]
Time to BCR (months); median [IQR]	22 [7.75, 36.8]

BCR, biochemical recurrence; IQR, interquartile range; PSA, prostate-specific antigen (excludes patients who never reached a PSA nadir)